Nevertheless, procalcitonin adds crucial information to the decision-making process; Esposito et al. showed that PCT-based protocol might decrease the use of antibiotics in pneumonia by approximately 15% [36], not only reducing the number of patients who receive antibiotics but also shortening the duration of antibiotic administration without any harm to the patients. This evidence concerns the gene CALCA and susceptibility to pneumonia measurement.